Advanced Diabetes Health

Your Body - Your Mind - Your Life

Blog Details

FDA Approves Orilissa For Endometriosis

by wochit 26 July 2018
FDA Approves Orilissa For Endometriosis

The U.S. Food & Drug Administration has approved a new pain medication for use in the treatment of endometriosis, a common gynecologic disorder. According to UPI, the biopharmaceutical company Abbvie, announced Tuesday the FDA has approved Elagolix as the brand name Orilissa. According to the U.S. Department of Health and Human Services, Endometriosis affects approximately 1 in 10 women of reproductive age, causing 30 percent to 40 percent of women with the condition to become infertile. The drug is expected to cost about $850 per month.


Free News Letter

subscribe-cover Sign up today for free to Nutrient Insider, our twice-weekly service and be the first to get the latest nutrient breakthroughs. You'll also get immediate access to our News Letter "How To Make Your Supplements Work Even Better".